摘要
目的 研究还原型谷胱甘肽(GSH)对SAP患者血清IL-6、IL-8及TNF-α含量的影响.方法 32例SAP患者按随机数字法分成GSH组及常规治疗组,各16例,选择年龄匹配的16名健康志愿者作为对照组.患者入院24 h内以及治疗7 d后采血检测血清中IL-6、IL-8和TNF-α水平.结果 SAP患者治疗前IL-6、IL-8和TNF-α水平分别为(81.34±5.99)ng/L、(97.81±15.61)ng/L和(28.21±1.53)ng/L,显著高于对照组的(16.69±2.86)ng/L、(26.42±1.59)ng/L和(15.89±1.41)ng/L(P＜0.05).治疗7 d后,GSH组的IL-6、IL-8和TNF-α水平分别为(31.21±3.88)ng/L、(35.51±1.27)ng/L和(16.15±1.31)ng/L,常规治疗组为(53.88±6.21)ng/L、(51.91±9.88)ng/L和(17.88±1.51)ng/L,均较治疗前显著下降(P＜0.05),GSH组下降程度显著大于常规治疗组(P＜0.05).结论 GSH能降低SAP患者血清炎症细胞因子水平,对治疗SAP有一定疗效.
Objective To investigate the effect of glutathione on serum IL-6, IL-8 and TNF-α levels in severe acute pancreatifis (SAP). Methods Thirty-six patients with SAP were randomly divided into glutathione treatment group and non-glutathione treatment group. Age-matched controls were enrolled from healthy volunteers. Serum levels of IL-6, IL-8, and TNF-α were measured within 24 h of admission and the seventh day after admission. Results The serum levels of IL-6, IL-8, and TNF-α in SAP patients were (81.34±5.99)ng/L, (97.81±15.61) ng/L and (28.21±1.53)ng/L, respectively, which were significantly higher than (16.69±2.86) ng/L, (26.42±1.59) ng/L and (15.89±1.41) ng/L in control group (P＜0.05). Seven days later, the serum levels of IL-6, IL-8, and TNF-α in glutathione treatment group were (31.21±3.88)ng/L, (35.51±1.27)ng/L and (16.15±1.31)ng/L, respectively, and those in non- glutathione treatment group were (53.88±6.21 ) ng/L, (51.91±9.88) ng/L, (17.88±1.51 ) ng/L, redpectively. The serum levels of IL-6, IL-8, and TNF-α at the seventh day after treatment were lower than those before treatment and the decrease in glutathione treatment group was more significant (P＜0.05). Conclusions Glutathione may reduce the serum levels of IL-6, IL-8, and TNF-＜ and may play a role in the treatment of SAP.
出处
《中华胰腺病杂志》
CAS
2008年第3期-,共3页
Chinese Journal of Pancreatology
